ArticleMaterials today. Bio2026

Biomimetic dual-driven STING nanoagonist orchestrates neoadjuvant mild photo-immunotherapy for fibrosarcoma.

Zhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.